CIK 0000009326 · Large accelerated filer
BALCHEM CORP
Sign in to watch- Ticker
- BCPC
- Exchange
- Nasdaq
- Industry
- Chemicals & Allied Products
- FY end
- Dec 31
- Incorporated
- MD
- Entity type
- operating
- EIN
- 132578432
- Phone
- (845) 326-5600
- Business address
- 5 PARAGON DRIVE, MONTVALE, NJ, 07645
- 4/A Derivatives Options or other derivatives
- 4 Grant or award General Counsel/Secretary acquired 1,135 shares (grant or award)
- 4 Grant or award VP/Gen Mgr/ARC Spec Prods acquired 577 shares (grant or award)
- 4 Grant or award President & CEO acquired 5,840 shares (grant or award)
- 4 Grant or award CFO acquired 2,031 shares (grant or award)
- 4 Shares withheld for taxes Chief Operating Officer gave up 654 shares (to pay taxes)
- 4 Open-market sale President & CEO sold 15,000 shares at an average $50.10 ($751,500)
- 4 Open-market sale CFO sold 14,000 shares at $51.48 ($720,724)
- 4 Open-market sale VP/Gen Mgr/ARC Spec Prods sold 13,500 shares at $50.74 ($684,974)
- 4 Open-market sale President & CEO sold 15,000 shares at an average $56.82 ($852,311)
- 4/A Open-market sale CFO sold 14,000 shares at $56.53 ($791,356)
- 4 Open-market buy CFO bought 14,000 shares at $56.53 ($791,356)
- 4 Open-market sale VP/Gen Mgr/ARC Spec Prods sold 13,500 shares at $56.05 ($756,663)
- 4 Open-market sale President & CEO sold 15,000 shares at an average $57.80 ($866,982)
- 4/A Open-market sale Director sold 6,000 shares at $57.48 ($344,880)
- 4 Open-market sale Director sold 8,243 shares at an average $57.13 ($470,896)
- 4 Open-market sale Director sold 8,000 shares at $58.40 ($467,200)
- 4 Open-market sale Director sold 5,000 shares at $56.23 ($281,150)
- 4 Grant or award Director acquired 1,957 shares (grant or award)
- 4 Grant or award Director acquired 1,957 shares (grant or award)
Page 20 of 34 · 677 filings